A Tumor Microenvironment Model of Chronic Lymphocytic Leukemia Enables Drug Sensitivity Testing to Guide Precision Medicine

The authors reported on a model that has reasonable associated costs, could be handled in a regularly equipped cell lab, and was compatible with ex vivo functional assays including drug sensitivity screens.